Work

Overall survival between veterans with metastatic castration-resistant prostate cancer treated with enzalutamide or abiraterone with kidney disease.

Year: 2025

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.5_suppl.76

Authors: Robert Wilson, Jason M Doherty, Suhong Luo, Danielle Candelieri-Surette, Daniel B. Eaton, Martin W. Schoen

Institutions: Saint Louis University, St. Louis VA Medical Center, University of Massachusetts Lowell, VA St. Louis Health Care System

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4407700434

Cites:

Cited by:

Related to: 10